Altermune Gets Boost with $7M Seed Funding via Loxbridge JV
By Jennifer Boggs
Friday, September 23, 2011
Founded based on an unusual idea for combating multiresistant pathogens, Altermune Technologies LLC is getting a business makeover, inking a joint venture deal with Loxbridge Research LLP that brings the biotech $7 million in seed funding and allows the firm's scientists to focus on advancing the technology.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.